Regorafenib-induced hyperammonemic encephalopathy
Author:
Affiliation:
1. Department of Medical Oncology; The Canberra Hospital; Garran ACT Australia
2. ANU Medical School; Australian National University; Acton ACT Australia
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12160/fullpdf
Reference16 articles.
1. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Demetri;Lancet,2013
2. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment;Trotti;Semin Radiat Oncol,2003
3. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors;Crona;Ann Pharmacother,2013
4. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Grothey;Lancet,2013
5. Imatinib-induced fatal acute liver failure;Ridruejo;World J Gastroenterol,2007
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example;Journal of Oncology Pharmacy Practice;2024-01-22
2. Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents;Revue Neurologique;2023-06
3. A Case of Non-cirrhotic Hyperammonemic Encephalopathy in a Patient With Metastatic Gastrointestinal Stromal Tumor;Cureus;2023-04-13
4. A case of hyperammonemia occurring during treatment of metastatic renal cell carcinoma with axitinib;IJU Case Reports;2023-04-11
5. Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma;Anticancer Research;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3